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Abstract
Salmonella genomic island 1 (variant SGI1-J3) has been previously identiﬁed in multi-drug resistant (MDR) Salmonella enterica serovar Vir-
chow isolated from humans in 1994. In this study, antimicrobial resistance, genotypes and genetic relationship were investigated in 96
S. Virchow isolates collected from humans in 2004–2006. XbaI-PFGE analysis separated 96 isolates into two main related clusters, I and
II, which consisted of four major pulsotypes differing in prevalence by year. The majority of isolates were MDR to chloramphenicol, sul-
fonamide, trimethoprim and tetracyclines associated with antimicrobial resistance genes dfrA1, ﬂoR2, sulI and tet(G) of variant SGI1-J3.
Among nine variants, we determined two novel variants, SGI1-J4 and -J5, which have undergone different homologous recombinational
events resulting in partial deletions of the MDR region. The ﬁrst one contained an empty integron structure and the second presented
a deletion extending from the IS6100 element to the adjacent SGI1 backbone. SGI1-J3 is largely encountered in clonally related MDR
S. Virchow isolates collected from humans, which spread vertically. The genomic island SGI1 appears to be largely responsible for the
diversity of MDR phenotypes among S. Virchow isolates in Taiwan.
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Introduction
Non-typhoidal Salmonella frequently causes food-borne out-
breaks in humans through consumption of Salmonella-
contaminated meats, eggs and poultry products [1]. Among
more than 2500 serovars, nearly 200 serovars are highly
pathogenic to humans [2]. In serogroup C1 Salmonella, S. ent-
erica serovar Choleraesuis (S. Choleraesuis) is highly virulent
in humans [3]. In contrast, S. Virchow is less virulent and has
frequently been isolated from contaminated vegetables,
broiler, chicken slaughterhouses and layer farms worldwide
[4–9]. This implicates a high correlation between human and
poultry isolates of S. Virchow [9]. In comparison to animal
isolates of S. Virchow, it has been reported in the United
Kingdom that human isolates carry more antimicrobial
resistance genes [10]. Recently, S. Virchow seems to have
become more invasive, as it is the second-ranking non-
typhoidal S. enterica serovar in Israel and gradually also
increasing in Taiwan [11,12], and has developed high resis-
tance to amikacin and gentamycin by the introduction of the
aminoglycoside resistance determinant rmtC [13].
Multidrug resistant (MDR) S. Virchow isolates have
increased and usually display resistance to nalidixic acid,
streptomycin, tetracycline, chloramphenicol and trim-
ethoprimsulfamethoxazole [14,15]. The genes for these anti-
microbial resistances are associated with class 1 integrons,
plasmids and the Salmonella genomic island 1 (SGI1) variant
SGI1-J [16–18]. SGI1 is a 43-kb integrative mobilizable
element initially characterized in worldwide epidemic
S. Typhimurium DT104 isolates [19,20]. SGI1 contains a
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complex class 1 integron responsible for the various MDR
phenotypes of several S. enterica serovars and also described
in Proteus mirabilis [19,20]. Recently, we reported in three
MDR S. Virchow isolates collected in Taiwan in 1994 an
unusual SGI1 variant (SGI1-J3) carrying the complex interg-
ron InSGI1-J3, which contains the dfrA1, ﬂoR2 (cmlA9), sul1
and tet(G) resistance genes [16]. For the ﬁrst time, this com-
plex integron was found inserted within ORF S023 of the
SGI1 backbone; most other complex integrons are inserted
at the same position between the resolvase gene and ORF
S044 at the 3¢ end of SGI1 [16]. A very similar SGI1-J variant
was also described in serovar Emek [21,22].
In the present study, 96 S. Virchow isolates collected from
patients between 2004 and 2006 in Taiwan were investigated
for the genetic variations in the antibiotic resistance gene
cluster of SGI1-J.
Materials and Methods
Bacterial isolates and identiﬁcation
From 2004 to 2006, 110 isolates were collected from faecal
and blood samples from patients who visited 19 medical cen-
tres and district hospitals throughout Taiwan. To avoid the
bias in selection, we chose 96 isolates for study based on an
even number in north, central and south Taiwan and dis-
carded some isolates between the borders. In addition, three
S. Virchow isolates harbouring the SGI1-J3 variant previously
characterized were also included in this study [16]. The ser-
ovar of all isolates was further conﬁrmed in our laboratory
by polymerase chain reaction (PCR) ampliﬁcation of target
genes for serogroup C1 with primer set 5¢-CAGTA GTCCG
TAAAA TACAGG GTGG-3¢ and 5¢-GGGGC TATAA
ATACT GTGTT AAATT CC-3¢ [23] and phase 1 antigen
(ﬂiC, r) with primer set 5¢-CCTGC TATTA CTGGT CATC-
3¢ and 5¢- GTTGA AGGGA AGCCA GCAG-3¢) [24].
Antimicrobial susceptibility
Antimicrobial susceptibility tests were performed by the disc
diffusion method and according to the guidelines of CLSI
standards [25] for ten antimicrobials, including ampicillin
(AMP, 10 lg), cefotaxime (CTX, 30 lg), ceftazidime (CAZ,
30 lg), ceftriaxone (CRO, 30 lg), chloramphenicol (CHL,
30 lg), ciproﬂoxacin (CIP, 5 lg), kanamycin (KAN, 30 lg),
nalidixic acid (NAL, 30 lg), streptomycin (STR, 10 lg), tetra-
cycline (TET, 30 lg) and trimethoprim/sulfamethoxazole (Sxt,
1.25 lg for trimethoprim and 23.75 lg for sulfamethoxazole),
which were purchased from BD (Becton, Dickinson and com-
pany, Sparks, MD, USA). E. coli (ATCC No. 25922) was used
as the control strain for antibiotic susceptibility testing [23].
MIC value to gentamycin (GEN) and CIP was determined by
Etest (AB bioMe´rieux, Solna, Sweden).
PFGE genotyping analysis
Genotyping was carried out by the PFGE method as described
previously [26]. Brieﬂy, embedded DNA was digested with the
restriction endonuclease XbaI (New England Biolabs, Ipswich,
MA, USA) at a concentration of 10 U/plug. Fragmented DNA
was further separated by CHEF DRIII (Bio-Rad Laboratories,
Richmond, CA, USA) gel electrophoresis in 0.5· TBE (45 mM
Tris borate, 1 mM EDTA, pH 8.3) at 14C. Switching times
ranged between 2.16 and 63.8 s, and the gel was run at 6 V/cm
with 120 switching angles for 19 h. The fragmented DNA pat-
tern of each isolate was recorded and analysed using an un-
weighted pair group method with arithmetic means (UPGMA)
using BIONUMERICS software (Applied Maths, Sint-Martens-
Latem, Belgium) to construct a phylogenetic tree with 3% opti-
mization and 1% position tolerance.
PCR mapping, Southern blot hybridization, cloning and
sequencing
Primers and PCR conditions used for serotyping, ampliﬁca-
tion of antimicrobial resistance genes and mapping of SGI1-J
are listed in Table S1 and were described previously
[11,21,27]. Detection of SGI1 and its chromosomal location
was performed using primers corresponding to the left and
right junctions in the chromosome as described previously
[16]. The presence of the central non-MDR region of SGI1
was assessed by Southern blot hybridization of whole geno-
mic DNA cut by XbaI (Promega, Charbonnieres, France) by
using probe p1-9 as previously described [2]. S. Typhimurium
DT104 strain BN9181 carrying SGI1 was used as a control
isolate. PCR products were commercially sequenced by
Beckman Coulter Genomics (Takeley, UK). Sequence analysis
was carried out by using BLASTN (available at http://
www.ncbi.nlm.nih.gov/blast). The partial sequence of this
SGI1-J variant of strain SV20 has been deposited in the Gen-
Bank database under accession number HM236854.
Results
Antimicrobial resistance and resistance genes
An early report demonstrated that the MDR region of the
SGI1-J consists of ﬂoR2 for CHL resistance, tetR and tet(G)
for TET resistance, and sulI and dfrA1 for Sxt resistance [2].
In this study, over 90% of isolates were MDR to CHL
(93.7%), Sxt (93.7%) and TET (90.6%) and NAL (94.8%) and
AMP (4.2%) (Table 1, Fig. 1). Except for ﬁve susceptible iso-
lates, the InSGI1-J-associated CSxtT antibiogram was
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observed in 93.4% (85/91) of isolates, CSxt antibiogram was
found in four isolates, and SxtT and CT antibiograms were
present in one isolate(Fig. 1). These results demonstrate that
variations in InSGI1-J occur in the tet region with the highest
frequency. In addition, almost all isolates were susceptible to
CIP, GEN, KAN and b-lactams, including AMP, CAZ, CRO
and CTX (Fig. 1). The blaTEM and blaCMY-2 for AMP resis-
tance and aac for gentamycin resistance were located on the
R plasmid.
New SGI1-J variants
While we ampliﬁed PCR junctions between the SGI1 back-
bone and InSGI1-J3 conﬁrmed that almost all isolates con-
sisted of the unusual insertion site of InSGI1-J3 within ORF
S023. In the present study, two isolates, SV20 and SV51,
studied by integron PCR mapping were negative for some
fragments, suggesting that in these isolates, SGI1 contained
different complex InSGI1-Js integrons. Further, four out of
ﬁve antimicrobial susceptible isolates, including SV20, were
positive for the junction PCR products between ORF S023
and the left (intI1 gene) and right (tniA gene) ends of InSGI1-
J. However, SV20 was negative for intI1-dfrA1, dfrA1-ﬂoR2,
ﬂoR2-tet(G) and tet(G)-sul1 PCRs, but positive for sul1-
IS6100 and IS6100-tniA PCRs. These results suggested the
presence of an empty integron attachment site. Thus, an
additional PCR was carried out between the integron-
encoded integrase gene intI1 and the sul1 gene. The resulting
PCR products were sequenced and a deletion was identiﬁed
that removed both the gene cassette and 472 bp of adjacent
sequences, including part of the attI1 site and part of the 3¢-
conserved segment (Fig. 2). According to the previously pro-
posed nomenclature of SGI1 [17], we propose to name this
SGI1 variant SGI1-J4 and its corresponding complex integron
InSGI1-J4.
The second S. Virchow isolate, SV51, displayed the classi-
cal antimicrobial resistance proﬁle (CSxtT) of SGI1-J3 and
yielded fragments of the sizes expected for all the integron
PCR mappings, except for the right part of InSGI1-J3 (i.e.
IS6100-tniA) and the right junction between tniA-S023. A
positive result for the fragment representing the link
between the sul1 gene and IS6100 would nevertheless sug-
gest the presence of at least a partial IS6100 element. To
characterize the InSGI1-J right junction, different PCRs were
performed using a forward primer in IS6100 and different
reverse primers in ORFs S023, S024 and S025. In a combina-
tion of the forward primer in IS6100 and the reverse primer
located in ORF S025, a fragment of 2379-bp was obtained
and sequenced. Compared with the nucleotide sequence of
SGI1-J3, sequence analysis using BLASTN revealed a precise
deletion that extended from the right inverted repeat of
IS6100 to position 23 168 (GenBank accession number
AF261825) within ORF S025 of the SGI1 backbone (Fig. 2).
We propose a new variant SGI1-J5 with InSGI1-J5. This spe-
ciﬁc deletion removed the 3¢ part of InSGI1-J3: (i) the adja-
cent segment of 152-bp derived from the IRt outer end of
Tn402, (ii) the right outer end of the mercury resistance
transposon Tn5058 containing the tniBD and tniA genes, and
(iii) the third IRt copy of Tn5058, and also a large region of
the SGI1 backbone: (i) the 5¢ end of ORF S023, (ii) the
entire ORF S024 and (iii) the 3¢ end of ORF S025 (Fig. 2).
To conﬁrm the location of the different complex integ-
rons within S023, a XbaI-Southern blot hybridization using
the p1-9 probe was performed for the strains harbouring
variants SGI1-J4 and -J5 and for seven SGI1-J3 strains. The
p1-9 probe showed two XbaI fragments, one fragment of
the expected 4 kb size as in the SGI1-carrying control
strains, and other different fragments larger than the
expected 9 kb size as in the SGI1-carrying control isolates.
The SGI1-J3 carrying S. Virchow isolates showed a 24.8 kb
fragment similar to the SGI1-J3 S. Virchow control isolate
B98. S. Virchow isolate SV20 containing the SGI1-J4 variant
produced a 15.4 kb fragment, which was in accordance with
the 9.4-kb deletion from the int to groEL/int region in its
complex integron compared with InSGI1-J3 (Fig. 2). The p1-9
probe did not hybridize to the second novel variant SGI1-J5
(strain SV51). This result was due to the deletion extending
from the InSGI1-J5 to the p1-9 corresponding region in the
SGI1-J5 variant.
TABLE 1. Susceptibility to 12 antimicrobials
Resistance classiﬁcation
The prevalence of resistance to (%)
AMPa CAZ CTX CHL STR TET NAL CIPb GENc CRO KAN Sxt
Susceptible 92 (95.8) 95 (99.0) 95 (99.0) 6 (6.3) 82 (85.4) 7 (7.3.2) 4 (4.2) 92 (95.8) 94 (97.9) 94 (97.9) 96 (100) 6 (6.3)
Resistance 4 (4.2) 1 (1.0) 0 (0) 90 (93.7) 0 (0) 87 (90.6) 91 (94.8) 0 (0) 2 (2.1) 0 (0) 0 (0) 90 (93.7)
aIsolates SV64, SV81, SV97 and SV51 were resistant to AMP and harboured a ca 90-kb R plasmid, which consists of blaTEM in isolates SV64, SV81 and SV97 and blaCMY-2 in
isolate SV51.
bIsolates SV04, SV12, SV17 and 19 had intermediate resistance to CIPb and had two mutations at S83F and N87D in GyrA and MIC value of 0.125–0.25 mg/L determined by
Etest.
cIsolates SV64 and 81 had resistance to gentamycin. The MIC value was 256 mg/L for SV64, 96 mg/L for transformant SV66/pSV64, and 24 mg/L for SV81 determined by
Etest, and >500 mg/L for all three isolates. The aac gene responsible for gentamycin resistance was on the large R plasmid.
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Genetic relatedness
Phylogenetic analysis of XbaI-digested PFGE patterns sepa-
rated the 96 isolates into two main clusters, I and II, with a
Dice similarity coefﬁcient >85% (Fig. 1). Among 96 isolates,
73 isolates belonged to four main XbaI-pulsotypes (19 iso-
lates in pulsotype 1, 18 isolates in pulsotype 3, 23 isolates in
pulsotype 8 and 13 isolates in pulsotype 9). These pulsotypes
varied in prevalence associated with years. Three S. Virchow
isolates from 1994 belonged to pulsotype 8 (isolate B94 and
B100), representing one of the most predominant pulso-
types, and pulsotype 20 (isolate B98), which has been absent
recently (Fig. 1). The majority of the isolates tested con-
tained the variant SGI1-J3 (Table S2). These results suggest
that spread of clonally-related MDR S. Virchow strains carry-
ing the SGI1-J3 variant has occurred in humans in Taiwan for
nearly two decades.
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FIG. 1. Dendrograms constructed with XbaI-PFGE patterns for 98 S. Virchow isolates. SGI1 variants are listed in Table S2. , resistant; h, sen-
sitive. A for ampicillin, C for chloramphenicol, S for streptomycin, Sxt for sulfamethoxazole/trimethoprim, and T for tetracycline. The dendro-
gram was generated by the the unweighted pair group method with arithmetic mean (UPGMA), using the Dice-predicted similarity value of two
patterns. The statistics program was provided by BIONUMERICS version 4.5, with settings of 1.0% optimization and 0.7% tolerance. Isolates B94
and B98 were isolated in 1994. H9812 is S. Braenderup used as standard size marker for PFGE analysis.
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Discussion
SGI1 is integrated into its speciﬁc attachment site at the 3¢
end of the chromosomal trmE gene (also called thdF).
According to the complex class 1 integron InSGI1-J3 that we
previously characterized in three S. Virchow isolates col-
lected in Taiwan in 1994, a PCR mapping was performed and
showed that 95 S. Virchow isolates were positive for SGI1.
Further, the PCR mapping results showed that 85 S. Virchow
isolates possessed the complete InSGI1-J3 complex integron
harbouring the following genes in this order: dfrA1 (TMP
resistance), ﬂoR2 (also named cmlA9, CHL and ﬂorfenicol
resistance), tetR and tet(G) genes (TET resistance), and sul1
(sulfonamide resistance). Moreover, InSGI1-J3 also contained
a partial transposition module at its 3¢ end as previously
described (Fig. 2) [16].
The deletion in the MDR region of InSGI1-J4 of SV20 was
precisely identical to that presented between the groEL/intI1
gene fusion and the sul1 gene in the complex integron InS-
GI1-J3 found in the genomic island SGI1-J3, also named SGI2
by Levings et al. (GenBank accession number AY963803)
[22]. The generation of the InSGI1-J4 can be explained by a
single crossover between the copies of the intI1 sequences
(intI1 and groEL/intI1 gene fusion) with a concomitant loss of
the central DNA region (Fig. 2). The generation of several
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FIG. 2. Genetic organization of the complex class 1 integrons in the different SGI1-J variants from S. Virchow strains. Black and grey arrows corre-
spond to SGI1 antibiotic resistance genes and chromosomal genes ﬂanking SGI1, respectively. DR-L and DR-R are the 18-bp left and right direct
repeats, respectively, bracketing SGI1. IRi and IRt are 25 bp imperfect inverted repeats deﬁning the left and right end of complex class 1 integrons.
The usual insertion point of the complex integron In104 or variants of it in SGI1 and the 5 bp target site duplication ﬂanking the complex integron
(InSGI1-J3, -J4) in ORF S023 are indicated (GenBank accession number EU924797). The p1-9 probe and XbaI restriction sites (X) are indicated.
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SGI1 variant MDR regions mostly appears to be a result of
genetic events that could have occurred by intramolecular
homologous recombination [19,20]. The deletion in the new
variant SGI1-J5 could be explained by an intramolecular
transposition of the IS6100 element leading to the insertion
of a second IS6100 copy within the ORF S025. Then, a single
crossover between the two IS6100 copies in the same orien-
tation would have resulted in the deletion of the central
region. The SGI1-J5 variant represented the third example of
IS6100-mediated genetic rearrangements within SGI1, the
others being SGI1-E and the recently described SGI1-T [28].
SGI1 is largely encountered in clonally related MDR S. Vir-
chow strains isolated from humans in Taiwan, with the most
prevalent variant being SGI1-J3. SGI1 MDR gene clusters are
subjected to recombinational events, which results in a great
diversity of MDR gene clusters, such as the new variants of
the SGI1-J subgroup described in this study. In addition,
recent reports have described for the ﬁrst time the 16S
rRNA methyltransferase RmtC protein, which confers high
levels of resistance on clinically important aminoglycosides, in
S. Virchow isolates found in the US and the UK, and that the
rmtC gene is located on the bacterial chromosome [10,29].
However, all of our isolates were sensitive to KAN, but only
two isolates, SV64 and SV81, were resistant to GEN, with
the MIC value of 256 mg/L for SV64, 96 mg/L for transfor-
mant SV66/pSV64, 24 mg/L for SV81 determined by Etest
and >500 mg/L for all three isolates determined by the mi-
crobroth method. The gene for such high level resistance to
GEN was aac, not the rmtC, on the R plasmid.
In a genetic relatedness study, two main genetic clusters, I
and II, showed a reverse trend in prevalence by years: a
gradual decrease of cluster I and increase of cluster II and a
gradual reduction in the number of pulsotypes from 13 in
2004 to 6 in 2006 (Fig. 1). Except that isolate SV99 lacked
the SGI1-J, the other 95 isolates consisted of full or partial
SGI1-J spread in all major clusters and pulsotypes (Fig. 1).
These results indicate the importance of SGI1-J in evolution-
ary beneﬁcial adaptation of speciﬁc genotypes over the years.
In this study, the majority of S. Virchow isolates harboured
the SGI-J3 variant, which conferred the largest MDR pheno-
type identiﬁed here. In conclusion, the great plasticity of the
MDR region of SGI1 associated with its ability to transfer
horizontally could contribute to its spread and persistence
among clinical enterobacteria.
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